CGON — CG ONCOLOGY INC
As of Q2 2026, 33 SEC-registered investment managers reported holding CGON (CG ONCOLOGY INC) in their latest 13F filings, with a combined reported value of $1.90B across 30.59M shares. That is +7.9% by share count (+2.24M shares) versus the previous quarter, while reported value moved +14.0%. Ownership is concentrated: the five largest holders account for 71.6% of reported value and the top ten for 89.1%.
Compared with the prior quarter, 2 opened new positions, 19 added to existing stakes, 10 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CGON is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.26M | $444.51M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 5.32M | $378.32M | 0.07% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.16M | $295.67M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 6.54M | $271.52M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 2.15M | $153.02M | 0.01% | Add |
| Franklin Resources history | Q2 2026 | 1.31M | $93.28M | 0.02% | Reduce |
| Morgan Stanley history | Q2 2026 | 1.18M | $83.63M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 984.92K | $69.98M | 0.01% | Reduce |
| UBS Group AG history | Q2 2026 | 977.70K | $69.47M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 857.71K | $60.94M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 677.91K | $48.17M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 627.18K | $44.56M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 417.73K | $30.99M | 0.00% | New |
| Farallon Capital Management history | Q2 2026 | 400.00K | $28.42M | 0.13% | Add |
| BNY Mellon history | Q2 2026 | 233.42K | $16.58M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 197.51K | $14.03M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 159.10K | $11.30M | 0.00% | Reduce |
| MFS Investment Management history | Q2 2026 | 155.39K | $11.04M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 135.22K | $9.61M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 102.40K | $7.28M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 417.73K sh · $30.99M
- Marshall Wace 4.18K sh · $297.34K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 18.50K sh · $1.25M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | 3.57M | 4.06M | 4.36M | 4.46M | 4.59M | 4.84M | 5.06M | 6.26M |
| Wellington Management Group | 198.81K | 201.37K | 510.22K | 1.91M | 2.13M | 1.90M | 5.51M | 6.00M | 5.37M | 5.32M |
| Fidelity Management & Research (FMR) | 157 | 174 | 145.61K | 2.43M | 2.55M | 3.86M | 3.87M | 4.30M | 3.76M | 4.16M |
| Geode Capital Management | 504.22K | 549.78K | 1.08M | 1.16M | 1.28M | 1.34M | 1.47M | 1.51M | 1.60M | 2.15M |
| Franklin Resources | 848.09K | 1.13M | 1.23M | 1.28M | 1.32M | 1.49M | 1.47M | 1.56M | 1.51M | 1.31M |
| Morgan Stanley | 73.72K | 94.71K | 234.87K | 725.23K | 945.08K | 1.87M | 642.41K | 545.02K | 520.21K | 1.18M |
| Bank of America Corp | 14.15K | 56.20K | 170.89K | 209.52K | 340.60K | 1.74M | 748.35K | 1.19M | 1.45M | 984.92K |
| UBS Group AG | 23.32K | 78.08K | 86.53K | 1.01M | 1.70M | 2.23M | 2.13M | 1.92M | 1.31M | 977.70K |
| Goldman Sachs Group | — | 471.09K | 649.57K | 818.67K | 767.27K | 1.19M | 1.37M | 1.32M | 1.16M | 857.71K |
| Northern Trust Corp | 183.00K | 183.98K | 381.44K | 433.86K | 471.76K | 468.10K | 491.34K | 481.94K | 519.67K | 677.91K |
| Charles Schwab Investment Management | 169.35K | 177.40K | 379.66K | 427.76K | 439.28K | 450.30K | 525.52K | 542.70K | 542.38K | 627.18K |
| JPMorgan Chase & Co | 9.54K | 19.53K | 31.07K | 168.87K | 122.18K | 54.09K | 227.88K | 586.83K | — | 417.73K |
| Farallon Capital Management | — | — | — | — | — | 8.00K | 8.00K | 8.00K | 200.00K | 400.00K |
| BNY Mellon | 64.54K | 89.34K | 144.93K | 135.57K | 147.56K | 146.66K | 159.59K | 155.16K | 167.03K | 233.42K |
| Deutsche Bank AG | 10.69K | 9.83K | 25.39K | 38.98K | 35.05K | 37.98K | 72.70K | 150.19K | 156.45K | 197.51K |
| Citadel Advisors | 278.46K | 507.99K | 341.56K | 1.22M | 1.17M | 262.15K | 267.77K | 777.89K | 267.81K | 159.10K |
| MFS Investment Management | 259.89K | 266.79K | 279.94K | 257.16K | 258.09K | 249.66K | 247.75K | 201.92K | 136.84K | 155.39K |
| Citigroup Inc | 4.28K | 10.61K | 35.21K | 71.64K | 95.88K | 50.13K | 36.37K | 17.69K | 14.20K | 135.22K |
| AQR Capital Management | — | — | — | — | 19.38K | 113.03K | 112.27K | 112.35K | 114.34K | 102.40K |
| D. E. Shaw & Co | — | — | — | — | — | 10.50K | 22.61K | 23.03K | 46.61K | 89.42K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details